Oxfordshire-based Brainomix’s stroke technology predicts patient recovery
PUBLISHED: 15:10 28 August 2018 | UPDATED: 15:10 28 August 2018
e-ASPECTS stroke technology
Archant
Brainomix is celebrating after a new study praised the usefulness of it’s e-ASPECTS stroke technology in hospitals
The technology allows clinicians - whatever their experience - to interpret CT brain scans on their mobile phones or tablets and quickly implement life-saving treatment for stroke victims.
The study, led by Prof Craig Anderson from The George Institute for Global Health, looked at 1,480 real-life CT scans from 111 hospitals in 13 countries.
e-ASPECTS scores were correlated with baseline neurological severity and independently predicted poor outcomes for stroke patients following thrombolysis - a procedure to dissolve blood clots.
It also showed it was a strong predictor of patient outcomes after thrombolysis, with a 1% decrease in the e-ASPECTS score associated with a 19% higher risk of a poor outcome for the patient.
Professor Simon Nagel, from Heidelberg University Hospital, first author of the study said: “In this large international clinical trial database (ENCHANTED), e-ASPECTS clearly predicted baseline neurological severity and prognosis in thrombolysed acute ischemic stroke patients.” Dr Michalis Papadakis, Brainomix CEO, added: “It’s encouraging to see the results from studies which are so positive.
“e-ASPECTS proved to be an excellent tool to predict the recovery and risk of haemorrhage of stroke patients following thrombolysis.”
For more information, visit the Brainomix website.
